Neurol. praxi. 2013;14(5):247-251

Peripheral neuropathies in malignancies

prof.MUDr.Zdeněk Ambler, DrSc.
Neurologická klinika LF UK a FN v Plzni

Peripheral neuropathies in a context of systemic malignancy may have a different cause and can manifest in various stages of development

of malignancy. They can be a direct effect of the primary malig nancy, a paraneoplastic syndrome, or a treatment complication.

Malignant neoplasms may infiltrate or compress peripheral nerves or roots, causing various sensory and motor symptoms. Paraneoplastic

syn dromes are rare, but they can precede a manifestation of the cancer itself. The most common is subacute sensory neuronopathy, sensorimotor

neuropathies are less common. Neuropathies may also be an indirect consequence of a dysimmune mechanism, for instance

in patients with lymphomas or vasculitis. Peripheral neurotoxicity is a side effect of many chemotherapeutic agents and can affect the

nerve fibers or the neuronal bodies. This side effect frequently represents one of their dose-limiting factors in cancer treatment. Both

brachial and lumbosacral plexopathies may develop as a complication of radiotherapy.

Keywords: peripheral neuropathy, neurolymphomatosis, paraneoplastic neuropathy, chemotherapy, neurotoxicity, radiotherapy

Published: October 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ambler Z. Peripheral neuropathies in malignancies. Neurol. praxi. 2013;14(5):247-251.
Download citation

References

  1. Agar M, Broadbent A, Chye R. The management of malignant psoas syndrome: case reports and literature review. J Pain Symptom Manage 2004; 28: 282-293. Go to original source... Go to PubMed...
  2. Antoine J-C, Camdessanché J-P. Peripheral nervous system involvement in patients with cancer. Lancet Neurol 2007; 6: 75-86. Go to original source... Go to PubMed...
  3. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Crit Rev Oncol Hematol 2012; 82: 51-77. Go to original source... Go to PubMed...
  4. Behin A, Psimaras D, Hoang-Xuan K, Leger J-M. Neuropathies in the context of malignancies. Curr Opin Neurol 2008; 21: 534-539. Go to original source... Go to PubMed...
  5. Dalmau J, Rosenfeld MR. Update on paraneoplastic neurologic disorders. Commun Oncol 2010; 7: 219-224. Go to original source... Go to PubMed...
  6. Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Pari?s J, Stirnemann J, Morin A-S, Gatfosse M, Hanslik T, Belmatoug N, Blétry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette A-M, Piette J-C, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza J-M, Kahn M-F, Guillevin L. Vasculitides associated with malignancies: Analysis of sixty patients. Arthritis & Rheumatism 2007; 57: 1473-1480. Go to original source... Go to PubMed...
  7. Falah M, Schiff D, Burns TM. Neuromuscular complications of cancer diagnosis and treatment. J Support Oncol 2005; 3: 271-282. Go to PubMed...
  8. Faltas B, Phatak P, Sham R. Mental nerve neuropathy: frequently overlooked clinical sign of hematologic malignancies. Am J Med 2011; 124: e1-2. Go to original source... Go to PubMed...
  9. Galán-Gil S, Pe?arrocha-Diago M, Pe?arrocha-Diago M. Malignant mental nerve neuropathy: systematic review. Med Oral Patol Oral Cir Bucal. 2008; 13: E616-621. Go to PubMed...
  10. Gikas PD, Hanna SA, Aston A, Kalson NA, Tirabosco R, Saifuddin A, Cannon SR. Post-radiation sciatic neuropathy: a case report and review of the literature. J Surg Oncol 2008, 6: 130 doi: 10.1186/1477-7819-6-130. Go to original source... Go to PubMed...
  11. Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G. PNS Euronetwork Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 2010; 67: 330-335. Go to original source... Go to PubMed...
  12. Gosk J, Rutowski R, Reichert P, Rabczyns J. Radiation-induced brachial plexus neuropathy - aetiopathogenesis, risk factors, differential diagnostics, symptoms and treatment. Folia Neuropathol 2007; 45: 26-30. Go to PubMed...
  13. Gozzard P, Maddison P. Which antibody and which cancer in which paraneoplastic syndromes? Pract Neurol 2010; 10: 260-270. Go to original source... Go to PubMed...
  14. Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 2012; 14: iv45-54. Go to original source... Go to PubMed...
  15. Grisold W, Oberndorfer S, Windebank AJ. Chemotherapy and polyneuropathies. Eur Assoc Neurooncol Mag 2012; 2: 25-36.
  16. Honnorat J, Antoine J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2007; 2: 22. Go to original source... Go to PubMed...
  17. Jaggi AS, Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology 2012; 291: 1-9. Go to original source... Go to PubMed...
  18. Jenkins RW, McDonald K, Greenberg CS. Numb chin syndrome in acute myeloid leukemia. Am J Med Sci 2012; 344: 237-240. Go to original source... Go to PubMed...
  19. Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve 2005; 31: 301-313. Go to original source... Go to PubMed...
  20. Koike H, Tanaka F, Sobue G. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol 2011; 24: 504-510. Go to original source... Go to PubMed...
  21. Lorusso L, Hart IK, Ferrari D, Ngonga GK, Gasparetto C, Ricevuti G. Autonomic paraneoplastic neurological syndromes. Autoimmun Rev 2007; 6: 162-168. Go to original source... Go to PubMed...
  22. Manji H. Toxic neuropathy. Curr Opin Neurol 2011; 24: 484-4903. Go to original source... Go to PubMed...
  23. Ramchandren S, Lewis RA. Monoclonal gammopathy and neuropathy. Curr Opin Neurol 2009; 22: 480-485. Go to original source... Go to PubMed...
  24. Rana SS, Ramanathan RS, Small G, Adamovich B. Paraneoplastic Isaacs' syndrome: a case series and review of the literature. J Clin Neuromuscul Dis 2012; 13: 228-233. Go to original source... Go to PubMed...
  25. Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol 2005; 18: 598-603. Go to original source... Go to PubMed...
  26. Sheikh SI, Amato AA. The dorsal root ganglion under attack: the acquired sensory ganglionopathies. Pract Neurol 2010; 10: 326-334. Go to original source... Go to PubMed...
  27. Shin HY, Park HJ, Choi YC, Kim SM. Clinical and electromyographic features of radiation-induced lower cranial neuropathy. Clin Neurophysiol 2013; 124: 598-602. Go to original source... Go to PubMed...
  28. Stevens MJ, Atkinson CC, Broadbent AM. The malignant psoas syndrome revisited: case report, mechanisms, and current therapeutic options. J Palliat Med 2010; 13: 211-216. Go to original source... Go to PubMed...
  29. Tschernatsch M, Singh P, Gross O, Gerriets T, Kneifel N, Probst C, Malas S, Kaps M, Blaes F. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy. J Neuroimmunol 2010; 226: 177-180. Go to original source... Go to PubMed...
  30. Vasić L. Radiation-induced peripheral neuropathies: etiopathogenesis, risk factors, differential diagnostics, symptoms and treatment. Arch Oncol 2007; 15: 81-84. Go to original source...
  31. Viala K, Béhin A, Maisonobe T, Léger J-M, Stojkovic T, Davi F, Leblond V, Bouche P. Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry 2008; 79: 778-782. Go to original source... Go to PubMed...
  32. Zapletalová O. Neurologické komplikace protinádorové léčby. Neurol. praxi 2003; 5: 249-252.
  33. Zivkovic SA, Ascherman D, Lacomis D. Vasculitic neuropathy - electrodiagnostic findings and association with malignancies. Acta Neurol Scand. 2007; 115: 432-436. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.